Resources Archive - Page 22 of 48

Poster Presentations at IMMUNOLOGY2024

Join WuXi AppTec at IMMUNOLOGY2024™. For this year’s annual meeting of the American Association of Immunologists (AAI), WuXi Biology has...

OncoWuXi Express: AAI 2024 Posters: Sneak Peek

OncoWuXi Express| Immunology 2024™ Poster Sneak Peek Introduction： OncoWuXi Express will continue to keep you informed about updates to our...

Discovery, Characterization, and Manufacture of Peptide Radiopharmaceuticals

A new wave of drugs that achieves targeted delivery of radioisotopes is rapidly gaining momentum. As the discovery pipeline widens...

Orthotopic and Metastasis Tumor Models in Rats

Rat tumor models are a better mimic of human pathology compared to mice. The tumor stroma component of rats is...

Syngeneic Tumor Models with Resistance Mechanisms to PD-1 Blockade

PD-1 blockade has demonstrated remarkable clinical efficacy across various tumor types. However, primary or acquired resistance eventually leads to cancer...

Armoring CAR-T Therapy with PD-1 Blockade

The efficacy of CAR-T therapy is substantially influenced by the tumor microenvironment. This is particularly evident when PD-L1 is activated...

Heme Oxygenase-1-Targeting Molecules

WuXi AppTec scientists published a study in the open access archive ChemRxiv describing the discovery of highly selective, novel, heme...

Custom Antibody and Protein Preparation Services

WuXi AppTec provides integrated and cost-effective services for: Polyclonal and monoclonal antibodies Anti-drug antibodies (ADA), host cell protein (HCP) antibodies,...

OncoWuXi Express: PSMA Overexpressing PC3 Tumor Model

Introduction： OncoWuXi Express will continue to keep you informed about updates to our on-line tumor model database (OncoWuXi Database), as...

Knowledge Library